Blueprint Medicines Corporation (BPMC) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Blueprint Medicines Corporation, Ultragenyx Pharmaceutical Inc..Total Return (%)
Blueprint Medicines Corporation (BPMC)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Blueprint Medicines Corporation
BPMC
Ultragenyx Pharmaceutical Inc.
RARE
Metric | Blueprint Medicines Corporation (BPMC) | Ultragenyx Pharmaceutical Inc. (RARE) |
---|---|---|
Current Price | $92.62 | $41.50 |
Change | 0.37 (0.40%) | -1.09 (-2.56%) |
Market Cap | $5.92B | $3.84B |
Trailing P/E | 0.00 | 0.00 |
Forward P/E | -98.53 | -8.12 |
Dividend Yield | 0.00% | 0.00% |
52-Week High | $121.90 | $60.37 |
52-Week Low | $80.67 | $37.02 |
Beta | 0.00 | 0.00 |
Earnings Per Share | $-1.07 | $-6.29 |
Processing data. Please try again later.
Average Return
Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
---|---|---|---|---|---|---|
BPMC | -18.67% | -18.67% | -2.56% | 56.29% | 390.83% | 390.83% |
RARE | -4.09% | -4.09% | -17.41% | -24.27% | -25.56% | -22.56% |